Raymond James & Associates’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-95
| Closed | -$223K | – | 3582 |
|
|
2018
Q3 | $223K | Sell |
95
-880
| -90% | -$2.07M | ﹤0.01% | 3205 |
|
|
2018
Q2 | $3.36M | Sell |
975
-40
| -4% | -$138K | 0.01% | 1426 |
|
|
2018
Q1 | $2.88M | Buy |
1,015
+5
| +0.5% | +$14.2K | 0.01% | 1467 |
|
|
2017
Q4 | $2.6M | Sell |
1,010
-136
| -12% | -$350K | ﹤0.01% | 1522 |
|
|
2017
Q3 | $3.25M | Buy |
1,146
+646
| +129% | +$1.83M | 0.01% | 1314 |
|
|
2017
Q2 | $1.18M | Buy |
+500
| New | +$1.18M | ﹤0.01% | 1920 |
|
|
2017
Q1 | – | Sell |
-84
| Closed | -$189K | – | 3228 |
|
|
2016
Q4 | $189K | Sell |
84
-47
| -36% | -$106K | ﹤0.01% | 2873 |
|
|
2016
Q3 | $327K | Sell |
131
-17
| -11% | -$42.4K | ﹤0.01% | 2551 |
|
|
2016
Q2 | $454K | Buy |
148
+36
| +32% | +$110K | ﹤0.01% | 2157 |
|
|
2016
Q1 | $355K | Sell |
112
-8
| -7% | -$25.4K | ﹤0.01% | 2227 |
|
|
2015
Q4 | $614K | Buy |
120
+14
| +13% | +$71.6K | ﹤0.01% | 1881 |
|
|
2015
Q3 | $337K | Buy |
106
+9
| +9% | +$28.6K | ﹤0.01% | 2093 |
|
|
2015
Q2 | $388K | Sell |
97
-1
| -1% | -$4K | ﹤0.01% | 2192 |
|
|
2015
Q1 | $390K | Sell |
98
-7
| -7% | -$27.9K | ﹤0.01% | 2129 |
|
|
2014
Q4 | $516K | Buy |
+105
| New | +$516K | ﹤0.01% | 1920 |
|